Forest Laboratories Holdings Limited
24 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
9
Ending by 2030
Oct 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 23, 2026The maintenance fee for Novel Crystalline Forms of TRANS-7-OXO-6-(SULPHOOXY)-1,6-Diazabicyclo[3,2,1]OCTANE-2-Carboxamide Sodium Salt (US 9,062,053) comes due Dec 23, 2026. Unpaid by Jun 23, 2027, it lapses early.
- 1 fee due Jun 29, 2027The maintenance fee for Methods for the synthesis of 1,3-substituted aminouracils and other xanthine-related compounds (US 9,221,821) comes due Jun 29, 2027. Unpaid by Dec 29, 2027, it lapses early.
- 1 fee due Aug 16, 2027The maintenance fee for Crystalline forms of (1S,2R)-2-(amino methyl)-N,N-diethyl-1-phenyl cyclopropane carboxamide (US 9,259,403) comes due Aug 16, 2027. Unpaid by Feb 16, 2028, it lapses early.
Recent changes
- 3 terms have ended since Aug 23, 2026
- Nov 12 US 7,612,087 Heterocyclic Compounds as Inhibitors of Beta-Lactamases · term ended
- Aug 29 US 7,803,838 Compositions Comprising Nebivolol · term ended
- Aug 26 US 8,815,870 4-(2-(6-Substituted-HEXYLIDENE) Hydrazinyl)benzonitrile and Preparation Thereof · lapsed on the fee record
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,838,552 | Compositions Comprising Nebivolol In force · High confidence | In force | High confidence | |
| US 8,227,623 | Process for the Preparation of Asenapine and Intermediate Products Used in Said Process In force · High confidence | In force | High confidence | |
| US 7,750,167 | Process for the Preparation of Asenapine and Intermediate Products Used in Said Process In force · High confidence | In force | High confidence | |
| US 7,964,739 | Process for the Preparation of Asenapine and Intermediate Products Used in Said Process In force · High confidence | In force | High confidence | |
| US 8,288,553 | Method for preparing disubstituted piperidine and intermediates In force · USPTO record | In force | USPTO record | |
| US 9,629,861 | Compositions and methods for treating bacterial infections using ceftaroline In force · USPTO record | In force | USPTO record | |
| US 9,062,053 | Novel Crystalline Forms of TRANS-7-OXO-6-(SULPHOOXY)-1,6-Diazabicyclo[3,2,1]OCTANE-2-Carboxamide Sodium Salt In force · High confidence | In force | High confidence | |
| US 9,580,424 | Novel Crystalline Forms of TRANS-7-OXO-6-(SULPHOOXY)-1,6-Diazabicyclo[3,2,1]OCTANE-2-Carboxamide Sodium Salt In force · High confidence | In force | High confidence | |
| US 9,259,403 | Crystalline forms of (1S,2R)-2-(amino methyl)-N,N-diethyl-1-phenyl cyclopropane carboxamide In force · USPTO record | In force | USPTO record | |
| US 8,247,400 | Cephem compounds useful for the treatment of bacterial infections In force · USPTO record | In force | USPTO record |
Also on record, not counted in the 15: 24 patents in force now held by others · 26 lapsed for an unpaid fee · 37 ended at full term · 2 surrendered on reissue. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 31 abandoned · 90 no status recorded